ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 100 filers reported holding ARATANA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,707,000 | -65.2% | 613,795 | -58.5% | 0.52% | -65.4% |
| Q4 2017 | $7,771,000 | -18.9% | 1,477,417 | -5.4% | 1.51% | -9.9% |
| Q3 2017 | $9,578,000 | -16.6% | 1,562,517 | -1.6% | 1.67% | -17.6% |
| Q2 2017 | $11,478,000 | +1.9% | 1,587,620 | -25.3% | 2.03% | +92.8% |
| Q1 2017 | $11,264,000 | +56.1% | 2,125,240 | +111.5% | 1.05% | -25.6% |
| Q4 2016 | $7,216,000 | -23.3% | 1,005,000 | 0.0% | 1.42% | -17.9% |
| Q3 2016 | $9,407,000 | +33.3% | 1,005,000 | -10.0% | 1.72% | +14.4% |
| Q2 2016 | $7,055,000 | +4.8% | 1,116,255 | -8.5% | 1.51% | +6.7% |
| Q1 2016 | $6,733,000 | +158.1% | 1,219,835 | +160.9% | 1.41% | +175.4% |
| Q4 2015 | $2,609,000 | -58.9% | 467,507 | -37.7% | 0.51% | -58.3% |
| Q3 2015 | $6,345,000 | -30.1% | 750,000 | +25.0% | 1.23% | -4.6% |
| Q2 2015 | $9,072,000 | -5.6% | 600,000 | 0.0% | 1.29% | -3.0% |
| Q1 2015 | $9,606,000 | -10.2% | 600,000 | 0.0% | 1.33% | -8.9% |
| Q4 2014 | $10,692,000 | – | 600,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
| AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
| Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
| GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
| Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
| WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
| Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |